ArticleFrontiers in medicine2026
The effect of Guipiheji (Guipi Mixture) combined with ferrous succinate tablets on improving iron deficiency anemia.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study is to investigate the effect of Guipiheji (Guipi Mixture) combined with ferrous succinate tablets on improving iron deficiency anemia (IDA). Methods: A retrospective analysis was conducted on 80 IDA patients admitted to Gongshu District People's Hospital of Integrated Traditional Chinese and Western Medicine from November 2024 to May 2025. Participants were assigned to an observation group ( Results: After treatment, levels of Hb, HCT, RBC, MCV, SI, iron saturation, and CD3 Conclusion: These results provide preliminary evidence that adding Guipiheji (Guipi Mixture) to ferrous succinate tablets is more effective in treating IDA. However, our study has some limitations. Specifically, we did not control for important confounding factors (including the severity of anemia, comorbidities, inflammation, concurrent medication use, menstrual blood loss, gastrointestinal malabsorption, renal function, and socioeconomic variables). Additionally, dietary intake, which may affect iron absorption and hematological outcomes, was not regulated in the research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.